- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02188095
Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
August 10, 2023 updated by: Aesculap AG
Clinical and radiological 10 year results of Excia T® Hip Stem
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bad Rappenau, Germany, 74906
- Vulpius Klinik
-
Stuttgart, Germany, 70176
- Diakonie Klinikum Stuttgart
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
primary care clinic
Description
Inclusion Criteria:
- Patient gave written informed consent
- age ≥ 18 years
Exclusion Criteria:
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Excia T®
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival Rate of the Implant
Time Frame: 10 years
|
Kaplan-Meier Survival Rate up to 10 years
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip disability and Osteoarthritis Outcome Score (HOOS)
Time Frame: preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 years
|
Documentation of clinical outcome with HOOS Score
|
preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 years
|
Change of functional outcome over follow-up period (Harris Hip Score (HHS))
Time Frame: at discharge, after 3 and 12 months 3, 5 and 10 years
|
The Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities.
|
at discharge, after 3 and 12 months 3, 5 and 10 years
|
Pain Assessment
Time Frame: at 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)
|
Pain will be measured with a Visual Analogue Scale (VAS), at rest and when walking on flat ground.
The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain).
The patients are asked to mark their current pain level on the line.
|
at 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)
|
Shaftposition ap and lateral
Time Frame: 10 years
|
Radiological documentation of shaftposition in ap and lateral view discharge, after 3 and 12 months and 3, 5, and 10 years
|
10 years
|
Stress Shielding
Time Frame: 10 years
|
Radiological documentation of stress shielding after 3 and 12 months and 3, 5, and 10 years
|
10 years
|
Hypertrophies
Time Frame: 10 years
|
Radiological documentation of hypertrophies after 3 and 12 months and 3, 5, and 10 years
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter Aldinger, Prof. Dr., Diakonie-Klinikum Stuttgart
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 3, 2014
Primary Completion (Actual)
October 6, 2015
Study Completion (Estimated)
July 1, 2025
Study Registration Dates
First Submitted
June 26, 2014
First Submitted That Met QC Criteria
July 10, 2014
First Posted (Estimated)
July 11, 2014
Study Record Updates
Last Update Posted (Actual)
August 14, 2023
Last Update Submitted That Met QC Criteria
August 10, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAG-O-H-1401
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Arthritis
-
Centre de l'arthrose, ParisRecruiting
-
Rutgers, The State University of New JerseyRecruitingTotal Hip Arthroplasty | Hip ArthritisUnited States
-
Klinički Bolnički Centar ZagrebUnknownHip Fractures | Knee Fracture | Knee Arthritis | Hip ArthritisCroatia
-
Kuopio University HospitalCompletedHip Arthritis | Total Hip Arthroplasty (THA)Finland
-
Göteborg UniversityCompletedTotal Hip Arthroplasty | Hip Arthritis | Gait AnalysisSweden
-
University of ArkansasCompletedKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthritis | Hip ArthritisUnited States
-
Ottawa Hospital Research InstituteNext Science TMRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthritis | Hip ArthritisCanada
-
Massachusetts General HospitalZimmer BiometActive, not recruitingOsteoarthritis of Hip | Traumatic Arthritis of HipUnited States
-
gosta ullmarkUnknownHip Osteo ArthritisSweden
-
Ottawa Hospital Research InstituteRecruitingHip Osteoarthritis | Hip ArthritisCanada